JW Holdings wins $10 million drug contract

Published: 2013-01-23 06:57:00

Updated: 2013-01-23 06:57:00

JW Holdings has won a contract to supply $10 million worth of Q-roxin (balofloxacin), a quinolone antibiotic and hair dye Changpo(n) to the Chinese market, the Korean pharmaceutical firm said Monday.

The company said it signed an agreement with Tianjin Green Fine Pharma to exports Q-roxin from 2016 after its registration approval from the Chinese health authorities (SFDA). Changpo(n) will be...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.